Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

VRDN Viridian Therapeutics Inc

13,01

0,23 (1,80%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:02:01

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Viridian Therapeutics Charts.

Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Viridian Therapeutics Charts.

News Viridian Therapeutics Inc

Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease
Dienstag 11 Juni 2024 (2 Wochen vor) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 10 Juni 2024 (3 Wochen vor) • Edgar (US Regulatory)

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Donnerstag 6 Juni 2024 (3 Wochen vor) • Business Wire

Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences
Freitag 31 Mai 2024 (4 Wochen vor) • Business Wire

Viridian Therapeutics to Participate in Upcoming May Investor Conferences
Freitag 10 Mai 2024 (2 Monate vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
Mittwoch 8 Mai 2024 (2 Monate vor) • Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 3 Mai 2024 (2 Monate vor) • Business Wire

Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024
Montag 29 April 2024 (2 Monate vor) • Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Donnerstag 4 April 2024 (3 Monate vor) • Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mittwoch 6 März 2024 (4 Monate vor) • Business Wire

Weitere Viridian Therapeutics Inc News-Artikel

Invesco QQQ Trust Series 1

JP Morgan Chase

Deutsche Telekom

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen